Effect of Fiber Supplementation on the Need for Medication With Gestational Diabetes
Recruiting now · Not applicable
Conditions studied: Gestational Diabetes Mellitus (GDM)
In brief
The hypotheses to be tested are 1) Fiber supplementation will decrease the need for medication in patients with gestational diabetes, and 2) Fiber supplementation will decrease adverse maternal and neonatal outcomes in these patients. In this study, the investigators will conduct a randomized controlled trial to limit bias in evaluating these hypotheses.
Key facts
- Study ID
- NCT06867861
- Run by
- Eastern Virginia Medical School
- People needed
- 110
- Starts
- 2025-02-24
- Expected to finish
- 2026-08-26
- Last updated by the study team
- 2025-03-10
Who can join
Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Singleton gestation
- Known or new diagnosis of gestational diabetes without reason for medication
- Age >=18 to <=50
You may not qualify if…
- - Non-English as primary language.
- Known or suspected fetal anomaly or aneuploidy.
- Known lower bowel disorder
- Known phenylketonuria
- Prisoners.
- Management of diabetes outside of Eastern Virginia Medical School Maternal Fetal Medicine.
Where it is running
- Macon & Joan Brock Virginia Health Sciences at ODU — Norfolk, Virginia, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.